Acetylon Pharmaceuticals' Grant

Acetylon Pharmaceuticals raised a round of funding on May 11, 2011. Investors include Leukemia & Lymphoma Society.

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human disease…

Articles about Acetylon Pharmaceuticals' Grant: